LBBW Aktienanleihe OMV 25.07.2025/ DE000LB4WFM3 /
9/9/2024 9:52:10 AM | Chg.+0.050 | Bid9/9/2024 | Ask9/9/2024 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
101.250EUR | +0.05% | 101.250 Bid Size: 250,000 |
101.450 Ask Size: 250,000 |
OMV AG | 31.36 EUR | 7/25/2025 | Call |
GlobeNewswire
3/26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
10/13/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center